Metformin is the world's most prescribed diabetes drug — and in 2026, it is also the world's most studied anti-aging medicine. An NIH-funded clinical trial called TAME is testing whether Metformin 1,500mg daily can delay the onset of cancer, heart disease, and dementia simultaneously in 3,000 non-diabetic Americans.